RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
Pfizer
Pfizer
Celgene
Medical University Innsbruck
University of Haifa
Gruppo Italiano Malattie EMatologiche dell'Adulto
Bicetre Hospital
University of Minnesota
European Organisation for Research and Treatment of Cancer - EORTC
Hospices Civils de Lyon
St. Justine's Hospital
Statens Serum Institut
Memorial Sloan Kettering Cancer Center
Assistance Publique - Hôpitaux de Paris